Orange Book product · Generic (ANDA)
ZIPRASIDONE MESYLATE
ZIPRASIDONE MESYLATE
Generic (ANDA)ANDA 216091TE APRX MSN
At a glance
Sep 15, 2022
Approved
Generic (ANDA)
Application
AP
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Sep 15, 2022
3 yr 10 mo ago
Today
Pharmaceutical detail
Active ingredient
ZIPRASIDONE MESYLATE
Strength
EQ 20MG BASE/VIAL
Dosage form
POWDER
Route
INTRAMUSCULAR
TE code
AP
Application
ANDA 216091
Product number
001
Marketing status
RX
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyGeneric (ANDA) of ZIPRASIDONE MESYLATE
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
